Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Affamed, Apellis, Biosyngen, BMS, Carsgen, CSL, Daiichi Sankyo, H. Lundbeck, Hanchorbio, Huidagene, Hutchmed, Innocare, Otsuka.